Although many studies have identified a link between hypercholesterolemia or hypertension and cognitive deficits, till date, comprehensive gene expression analyses of the brain under these conditions is still lacking. The present study was carried out to elucidate differential gene expression changes in the prefrontal cortex (PFC) of New Zealand white rabbits exposed to hypercholesterolemia and/or hypertension with a view of identifying gene networks at risk. Microarray analyses of the PFC of hypercholesterolemic rabbits showed 850 differentially expressed genes (DEGs) in the cortex of hypercholesterolemic rabbits compared to controls, but only 5 DEGs in hypertensive rabbits compared to controls. Up-regulated genes in the PFC of hypercholesterolemic rabbits included CIDEC, ODF2, RNASEL, FSHR, CES3 and MAB21L3, and down-regulated genes included FAM184B, CUL3, LOC100351029, TMEM109, LOC100357097 and PFDN5. Comparison with our previous study on the middle cerebral artery (MCA) of the same rabbits showed many differentially expressed genes in common between the PFC and MCA, during hypercholesterolemia. Moreover, these genes tended to fall into the same functional networks, as revealed by IPA analyses, with many identical node molecules. These include: proteasome, insulin, Akt, ERK1/2, histone, IL12, interferon alpha and NFkB. Of these, PSMB4, PSMD4, PSMG1 were chosen as representatives of genes related to the proteasome for verification by quantitative RT-PCR. Results indicate significant downregulation of all three proteasome associated genes in the PFC. Immunostaining showed significantly increased number of Ab labelled cells in layers III and V of the cortex after hypercholesterolemia and hypertension, which may be due to decreased proteasome activity and/or increased b-or g-secretase activity. Knowledge of altered gene networks during hypercholesterolemia and/or hypertension could inform our understanding of the link between these conditions and cognitive deficits in vascular dementia or Alzheimer's disease.
Introduction
Metabolic syndrome which is related to the presence of several conditions that are related to central obesity, such as aberrant glucose metabolism, dyslipidemia and hypertension, is associated with increased risk of type 2 diabetes mellitus and coronary artery disease (Panza et al., 2008 ). In addition, many studies have reported the association of metabolic syndrome with increased risk of agerelated cognitive deficits (Ho et al., 2008) , vascular dementia (Solfrizzi et al., 2010 ) and Alzheimer's disease (AD) (Rios et al., 2014; Watts et al., 2013) . Increased plasma or serum cholesterol levels (Jarvik et al., 1995; Kuo et al., 1998; Pappolla et al., 2003) , increased low-density lipoprotein (LDL) cholesterol (Kuo et al., 1998; Lesser et al., 2001) , or decreased high-density lipoprotein (HDL) cholesterol (Bonarek et al., 2000; McGrowder et al., 2011; Merched et al., 2000; van Exel et al., 2002) have been associated with increased susceptibility to AD. In contrast, elderly individuals with elevated HDL cholesterol have reduced risk of AD (Reitz et al., 2010) . Statins that reduce cholesterol biosynthesis, have been reported to reduce the risk of late-onset AD (Haag et al., 2009 ) and help in prevention of AD (Silva et al., 2013) .
Induction of hypercholesterolemia in rabbits results in increased deposition of cerebral b-amyloid (Ab) (Sparks et al., 1994) . Likewise, induction of hypercholesterolemia in the amyloid-b protein precursor (APP)/presenilin-1 (PS-1) double-transgenic mouse model accelerates Ab pathology (Refolo et al., 2000) . AD mice fed with a high cholesterol diet show greater impairment of spatial learning than those on a normal diet . This deficit is associated with an AD-like pathology, such as increased cortical Ab and phosphorylated tau (Granholm et al., 2008; Ullrich et al., 2010) . Cholesterol lowering-drugs decrease cholesterol levels not only in the plasma but also the brain, after high fat/cholesterol diet and reduce Ab formation (Refolo et al., 2001) . Besides hypercholesterolemia, hypertension is a risk factor for vascular dementia (Gorelick et al., 2011) and AD (Faraco and Iadecola, 2013; . Increased amyloid plaques and neurofibrillary tangles are found in the brains of patients with hypertension (Rodrigue et al., 2013) , and elevated midlife diastolic blood pressure is associated with amyloid angiopathy and risk of AD (Shah et al., 2012) . Ab-immunoreactivity and Ab-fragments are found in areas of blood-brain-barrier (BBB) damage, in mouse models of hypertension (Carnevale and Lembo, 2011; Gentile et al., 2009) .
Although the above studies have identified a link between hypercholesterolemia and/or hypertension and cognitive deficits, till date, comprehensive gene expression analyses of the brain under these conditions is lacking. The present study was carried out to elucidate differential gene expression changes in the prefrontal cortex (PFC) of New Zealand white rabbits exposed to hypercholesterolemia and/or hypertension, with a view of identifying genes and networks at risk.
Materials and methods

Animals
The cholesterol-fed New Zealand white rabbit is the gold standard animal model in atherosclerosis studies (Yanni, 2004) . It is often used as a non-transgenic animal model to study the detrimental effect of hypercholesterolemia on the brain (Marwarha et al., 2010) , as it demonstrates several of the pathological markers of AD (Deci et al., 2012; Ghribi et al., 2006; Sparks et al., 1994 Sparks et al., , 2000 Sparks and Schreurs, 2003) . We decided to use rabbits rather than rodents in this study, as we wanted to compare the effects of hypercholesterolemia and/hypertension in the same species, and also wanted to avoid a genetic model of hypercholesterolemia, which might affect the interpretation of global gene expression results. It is difficult to induce hypercholesterolemia in rodents (Russell and Proctor, 2006) , although hypertension can be produced (Doggrell and Brown, 1998) . There is also greater similarity between rabbits and humans, both genetically (Graur et al., 1996) and in their Ab sequence (Johnstone et al., 1991) .
Male rabbits of approximately 8 weeks old (young adults) and weighing 2.0e2.5 kg each at the start of the experiments were used. Three sets of analyses were carried out: i) to determine gene expression changes in the PFC after hypercholesterolemia plus sham operation, ii) to determine gene expression changes in the PFC after hypercholesterolemia plus hypertension, and iii) to determine gene expression changes in the PFC after hypertension. The Goldblatt 2-Kidney 1-Clip (2K1C) method was used to induce hypertension. Analyses were carried out on: a) 6 rabbits on a high cholesterol diet plus sham operation. b) 6 rabbits on a high cholesterol diet plus the 2K1C method to induce hypertension. c) 6 rabbits with 2K1C-induced hypertension and fed with normal diet. d) 6 sham-operated controls on a normal diet (controls). Rabbits were sacrificed at the end of 12 weeks after surgery or sham operation.
The 2K1C procedure to induce hypertension was performed as previously described (Akabane et al., 1985; Ong et al., 2013) . Animals in the 'hypercholesterolemia plus sham/hypertension' groups were allowed to recover for 1 week after surgery before proceeding with dietary treatment containing cholesterol. The diet for these groups of rabbit was GPR diet þ1% cholesterol (Glen Forrest Stockfeeders, Australia). 'Sham operated control' rabbits were fed with GPR diet without cholesterol. All procedures including animals were approved by the Institutional Animal Care and Use Committee of the National University of Singapore, and carried out in accordance with guidelines of the National Advisory Committee for Laboratory Animal Research.
2.2. Measurement of body weight, mean arterial pressure and serum total cholesterol Rabbits were anaesthetized by intramuscular injection of ketamine/xylazine cocktail, and mean arterial pressure measurements and blood collection carried out as previously described (Ong et al., 2013) .
Tissue harvesting and RNA extraction
The different groups of rabbits were sacrificed and tissues harvested as previously described (Ong et al., 2013) .
DNA microarray analysis
Ten mL of total RNA from the PFC of four rabbits from each group were submitted to Genomax Technologies, Singapore. RNA quality was validated using an Agilent 2100 Bioanalyzer (Agilent Technologies, CA, USA). cRNA was generated, labelled using the onecycle target labeling method, and hybridized to the 1-colour Agilent Rabbit Microarray (G2519F-020908; Agilent Technologies), according to the manufacturer's protocol. Data was collected and exported to GeneSpring v11 software for analysis, using a parametric test based on the cross gene error model (Agilent Technologies). Differentially expressed genes (DEGs) are those that show significantly increased or decreased expression compared with 'sham operated controls' using one-way ANOVA with Tukey HSD post-hoc test, and corrected for multiple comparisons using Benjamini Hochberg FDR (P < 0.01). DEGs from the 'hypercholesterolemia plus sham' operated group vs. 'sham operated controls' were also compared between the PFC and MCA, using unpaired Ttest and Benjamini Hochberg FDR (P < 0.01). Data for the MCA was based on our previous study (Ong et al., 2013) , which used the same rabbits as this study. To minimize false positives, only DEGs with greater than 4-fold change (or in the case of common genes between two data sets greater than 4-fold change in at least one data set) with P < 0.01 were presented, and used for Ingenuity Pathway Analysis (IPA) analyses, below.
Network analyses
DEGs in the PFC were further analyzed by IPA software (Ingenuity ® Systems, www.ingenuity.com), to elucidate possible functional interactions between genes. Identifiers and corresponding expression values of up-or down-regulated DEGs with more than 4-fold change were uploaded into the IPA software. Each identifier mapped to its corresponding object, and was overlaid onto a global molecular network in the Ingenuity ® Knowledge Base.
Focus Genes (Network Eligible genes) are defined as DEGs that have at least one other molecule that interacts with it, in the Knowledge Base. 
Real-time RT-PCR
The mRNA expression of five genes: PSMB4 (proteasome subunit beta 4), PSMD4 (proteasome 26S subunit, non-ATPase 4), PSMG1 (proteasome assembly chaperone 1), and INS (insulin) and APP were selected for analyses by real-time RT-PCR. PSMB4, PSMD4 and PSMG1 were chosen as they are associated with the proteasome, which is a 'node molecule' identified by IPA analyses in both Italics denotes DEG that is in common between the PFC and MCA with more than 4-fold change in the MCA. the PFC (the present study) and the MCA (Ong et al., 2013) . Purified RNA from the PFC of 4 'hypercholesterolemia plus sham' group vs. 'sham operated controls' were reverse-transcribed with the HighCapacity cDNA Reverse Transcription Kit (Applied Biosystems, CA, USA). Reaction conditions were 25 C for 10 min, 37 C for 120 min and 85 C for 5 s. Real-time PCR amplification was performed using the 7500 Real time PCR system with TaqMan ® Universal PCR Master
Mix and probes. The PCR conditions were initial incubation of 50 C for 2 min and 95 C for 10 min, followed by 40 cycles of 95 C for 15 s and 60 C for 1 min. Rabbit TaqMan ® probes were purchased from Applied Biosystems. Rabbit b-actin TaqMan ® probe was used as an internal control. Fold change in expression was calculated using the 2-delta delta CT method as previously described (Livak and Schmittgen, 2001 ). Possible differences between the means were analyzed using Student's t-test. P < 0.05 was considered significant.
Immunohistochemistry
PFC tissues were dehydrated in graded ethanol and embedded in paraffin. They were sectioned at 5 mm thickness, mounted on gelatin-coated slides, deparaffinized with xylene, and rehydrated through graded concentrations of ethanol. Sections were incubated with 5% normal donkey serum (Vector Laboratories, CA, USA) and 0.1% Triton X-100 for 1 h, followed by mouse monoclonal antibody to Ab (clone 4G8, SIG-39220; Signet/Covance, MA, USA; diluted 1:500 in PBS) overnight. They were then washed three times in PBS and incubated with biotinylated anti-mouse secondary antibody. Immunoreaction product was visualized using an avidinbiotinylated horseradish peroxidase kit (Vector Laboratories). Sections were mounted on glass slides and viewed using a light microscope (BX51, Olympus, Japan). Ab labelled cells in layers III and V of the PFC were counted at 20Â objective magnification, and recorded as cells per image (area of 0.5 mm 2 ) with 6 images per animal. The mean and standard deviation were calculated and possible differences between groups analyzed, using one-way ANOVA with Bonferroni's multiple comparison post-hoc test. P < 0.05 was considered significant.
Results
Body weight, mean arterial pressure and serum total cholesterol levels
The mean body weight, mean arterial pressure and serum total cholesterol levels of rabbits in the various treatment groups have been reported in our previous study (Ong et al., 2013) .
Microarray analyses of the FC
Microarray analyses of the 'hypercholesterolemia plus sham' group
Gene expression profiles in the PFC of the 'hypercholesterolemia plus sham' group were compared with those of 'sham operated controls' on a normal diet. After unknown and repeated genes were omitted, a total of 858 DEGs was found (Fig. 1A) . These included 575 up-regulated (Fig. 1B ) and 283 down-regulated genes (Fig. 1C) (greater than 4-fold change). Among the highly up-regulated genes in the PFC of the 'hypercholesterolemia plus sham' group compared with 'sham operated controls' were CIDEC, ODF2, RNASEL, FSHR, CES3, and MAB21L3 (Table 1) . Among the highly down-regulated genes were FAM184B, CUL3, LOC100351029, TMEM109, LOC100357097, and PFDN5 (Table 2) .
The DEGs were imported into IPA to analyze network interactions. The network with the 'largest number of up-regulated focus genes' contained 22 focus genes with functions in Lipid Metabolism, Molecular Transport, and Small Molecule Biochemistry. Focus genes in this network were AOC1, CD244, CP, DEPTOR, ELK3, ELOVL3, FBP1, FGF19, GPRIN2, IL20RA, KLB, KLF13, MLXIP, OVGP1, PKMYT1, PLA2G1B, RASGRP4, RPTOR, SH2D1A, SULT2A1, SYNPO2, and TPH2 (Fig. 2) . They are related to the 'node molecule' ERK1/2. The second network of up-regulated focus genes had 22 focus genes, with functions in Humoral Immune Response, Protein Synthesis, and Endocrine System Disorders. Focus genes in this network were CARD11, CHFR, CORIN, DUOX2, EPHB3, FCRLA, IL25, IL2RB, INO80D, LAX1, MS4A2, NFRKB, PAX9, PIGR, PLD1, PROK1, PROKR2, SP4, TBX18, TBX21, TCL1A, and TPO (Fig. 3) . They are Italics denotes DEG that is in common between the PFC and MCA with more than 4-fold change in the MCA. Italics and bold denote DEG that is in common between the PFC and MCA with more than 10-fold change in the MCA.
associated with Akt, BCR (complex), IgE, IgG1, and IgM. The network with the largest number of down-regulated focus genes contained 24 focus genes with functions in Cancer, Cell Cycle, Cellular Assembly and Organization. Focus genes in this network were ASF1A, ECT2, ELOVL5, FAM188A, IFRD1, INPP4A, INSIG2, KLF1, MCM4, MYBBP1A, NCKAP1, NGB, PARD6B, PELP1, PSMC6, PSMD4, RPN1, SAP30, SMARCA5, SMARCD1, SMARCD3, SPRR3, SUCLG1, and TYMS (Fig. 4) . They are related to Akt, Cyclin A, Cyclin E, E2f, Hdac, and Histone h4. The second network of down-regulated focus genes had 23 focus genes, which are related to Protein Synthesis, Infectious Disease, Cell Death and Survival. Focus genes in this network included ATP2A3, CCNH, CCT2, DDX58, EIF2S1, EIF3B, EIF3M, ENAH, FGL2, GAPDH, IRAK1BP1, MYO1E, NCBP1, NCK1, PFDN5, PGK2, TBK1, TPT1, TRIM37, TSPAN6, TUBB1, USP3, and VBP1 (Fig. 5) . They are related to Alpha tubulin, BCR (complex), Beta Tubulin, Ifn, IFN Beta, IFN type 1, Ikb, NFkB (complex), Proinflammatory Cytokine, and Sos.
Microarray analyses of the 'hypercholesterolemia plus hypertension' group
Gene expression profiles in the PFC of the 'hypercholesterolemia plus hypertension' group were compared with those of 'sham operated controls' on a normal diet. After unknown and repeated genes were omitted, a total of 971 DEGs was observed (Fig. 1A) . These included 870 up-regulated (Fig. 1B) and 101 down-regulated genes (Fig. 1C) (greater than 4-fold change). Among the highly upregulated genes in the PFC of the 'hypercholesterolemia plus hypertension' group compared with 'sham operated controls' were CIDEC, FSHR and FGFBP2 (Table 3) . Among the highly downregulated genes were GAPDHS, FAM184B and TTR (Table 4) .
The IPA network with the 'largest number of up-regulated focus genes' contained 26 focus genes with functions in Cell Signaling, Cell-To-Cell Signaling and Interaction, and Nucleic Acid Metabolism. Focus genes in this network were ADRA1A, AVPR1B, BDKRB1, CALCRL, CCR10, CHRM2, FZD4, GHRHR, GPR18, GPR52, GPR115, GPR119, GPR156, GPR174, GPR182, HRH1, HTR4, LGR5, NMBR, NPFFR1, P2RY10, PTGER3, RXFP1, RXFP2, TACR2, and VIPR2 ( Fig. 6) . They are related to GPCR.
The IPA network with the 'largest number of down-regulated focus genes' contained 20 focus genes with functions in Cellular Movement, Infectious Disease, Cell Death and Survival. Focus genes in this network were CCT2, CRYAA/LOC102724652, EIF2S1, ELOVL2, FABP7, FGF16, GUCY1B3, INSL6, KRAS, LGI1, MMP9, ORMDL3, PFDN5, PRKCB, PSMC6, SLC2A3, TMEM109, TNFRSF11B, TUBB1, and UTS2. They are related to Beta tubulin, Cyclin E, ERK1/2, growth hormone, Insulin, LDL, MAP2K1/2, Mek, STAT5a/b and Tgf beta (Fig. 7) .
Microarray analyses of the 'hypertension only' group
Gene expression profiles in the PFC of the 'hypertension only' group were compared with those of 'sham operated controls' on a normal diet. After unknown genes and repeated probes of the same genes were omitted, a total of 5 DEGs was observed (Fig. 1A) . These included one up-regulated (Fig. 1B) and four down-regulated genes (Fig. 1C) (greater than 4-fold change). CCNB1IP1 was the only upregulated gene in the PFC of the 'hypertension only' group compared with 'sham operated controls' (Table 5 ). Among the highly down-regulated genes were OTUD6A and GNMT and C1QTNF1 (Table 6) .
Only one IPA network with the one up-regulated focus gene, CCNB1IP1, was detected, and it has functions in Cell Cycle, Dermatological Diseases and Conditions, Reproductive System Development and Function (Fig. 8) .
The network with the largest number of down-regulated focus genes contained only 2 focus genes, with functions in Lipid Italics denotes DEG that is in common between the PFC and MCA with more than 4-fold change in the MCA. Italics and bold denote DEG that is in common between the PFC and MCA with more than 10-fold change in the MCA.
Metabolism, Molecular Transport and Small Molecule Biochemistry. Focus genes in this network were C1QTNF1 and GNMT; they are related to NR3C1 (Fig. 9 ).
Real-time RT-PCR
The mRNA expression of PSMB4, PSMD4, PSMG1 and APP were significantly downregulated in the PFC of the 'hypercholesterolemia plus sham' group as compared to the 'sham operated control' group (P ¼ 0.0022, P ¼ 0.0016, P ¼ 0.0184, P ¼ 0.0054, respectively; Fig. 10A ). No significant difference in the mRNA expression of insulin (INS). Possible links between node molecules and Ab are summarized in Fig. 10B .
Immunohistochemistry
Immunostaining with Ab antibody showed few labelled cells in the PFC of the 'sham operated control' group. In contrast, many densely labelled cells were observed in layers III and V of the 'hypercholesterolemia plus sham' and 'hypercholesterolemia plus hypertension' groups (Figs. 11e13) . Many large Ab immunolabelled cells had a prominent apical dendrite and were identified as pyramidal neurons. Other large cells lacked an apical dendrite, and were identified as non-pyramidal neurons ( Fig. 12I and J) . The possibility that some labelled cells were glial cells cannot be ruled out. The number of labelled cells were significantly greater in layer III of the 'hypercholesterolemia plus sham', and 'hypercholesterolemia plus hypertension' groups, compared to the 'sham operated control' group (P ¼ 0.0025 and P ¼ 0.0028, respectively). The number of labelled cells was also significantly greater in layer V of the 'hypercholesterolemia plus sham', and 'hypercholesterolemia plus hypertension' groups, compared with the 'sham operated control' (P ¼ 0.0014 and P ¼ 0.0002, respectively) and 'hypertension only' groups (P ¼ 0.0144 and P ¼ 0.0018, respectively) (Fig. 13) .
Discussion
The present study was carried out to elucidate differential gene expression changes in the PFC of rabbits exposed to hypercholesterolemia and/or hypertension. Among the DEGs in the PFC that were up-regulated in the 'hypercholesterolemia plus sham' vs. 'sham operated controls' on a normal diet, CIDEC had the highest fold change, followed by ODF2, RNASEL, FSHR, CES3, and MAB21L3. CIDEC (cell death-inducing DFFA-like effector c) is a member of the Cell deathInducing DNA fragmentation factor 45-like Effector (CIDE) family with functions in apoptosis, energy metabolism (Yonezawa et al., 2011) and lipid metabolism . Overexpression of CIDEC induces DNA fragmentation and apoptosis (Liang et al., 2003) . CIDEC and CIDEA are found in white adipose tissue, and their expression is correlated with the formation of lipid droplets (Puri et al., 2008) . CIDEC or fat specific protein of 27 kDa (Fsp27) Liang et al., 2003) is also up-regulated in the liver of obese and high-fat diet-induced mice (Matsusue et al., 2008) , and humans with hepatic steatosis . It may be involved in the formation of foam cells in atherosclerotic blood vessels (Li et al., 2010) and the development of metabolic disorders (Gong et al., 2009 ). ODF2 (outer dense fiber of sperm tails 2) is a testis gene and a transcriptional target of hypoxia (Baghbani et al., 2013) . It is a component of the cytoskeleton of sperm (Baghbani et al., 2013) and has functions in spindle formation and cell division (Donkor et al., 2004) . RNASEL (ribonuclease L (2 0 ,5'-oligoisoadenylate synthetase-dependent)) is involved in the function of Table 4 Down-regulated genes in the PFC of the 'hypercholesterolemia plus hypertension' rabbits vs. 'sham operated control' rabbits with greater than 10-fold change.
Gene
Gene symbol Italics denotes DEG that is in common between the PFC and MCA with more than 4-fold change in the MCA. Italics and bold denote DEG that is in common between the PFC and MCA with more than 10-fold change in the MCA.
interferon and plays a role in anti-cellular proliferation, apoptosis, autophagy and regulation of gene expression (Chakrabarti et al., 2012; Liang et al., 2006) . RNASEL is important in macrophage functions such as migration and cytokine production (Yi et al., 2013) . FSHR (follicle stimulating hormone receptor) is a receptor for follicle stimulating hormone (Corbo et al., 2011) . Certain FSHR genotypes have been reported to protect against AD susceptibility (Corbo et al., 2011) . CES3 (carboxylesterase 3) plays a role in basal fatty acid efflux (Wei et al., 2007) . Treatment of mouse models of obesity-diabetes with a Ces3 inhibitor ameliorates multiple features of metabolic syndrome (Dominguez et al., 2014 ). There is not much known about the function of MAB21L3 (Protein mab-21-like 3). Among the down-regulated DEGs in the PFC of the 'hypercholesterolemia plus sham' vs. 'sham operated controls' on a normal diet were FAM184B with the highest fold change, followed by CUL3, LOC100351029, TMEM109, LOC100357097, and PFDN5. There is not much known about the function of FAM184B (family with sequence similarity 184, member B). CUL3 (cullin 3) is a member of the cullin family, involved in post-translational modification of proteins such as ubiquitination (Anderica-Romero et al., 2013) . It has been suggested to play a role in chronic diseases related to oxidative stress (Anderica-Romero et al., 2013). There is not much known about the functions of LOC100351029 (glutamate dehydrogenase 1-like), TMEM109 (transmembrane protein 109) and LOC100357097 (progesterone receptor membrane component 1). PFDN5 (prefoldin subunit 5) is a member of a family of molecular chaperones that binds and stabilizes newly synthesized polypeptides, thereby allowing them to fold correctly. Knockdown of PFDN5 results in formation of aggregates of Huntingtin protein (Tashiro et al., 2013) . PFDN5 is also a tumor suppressor gene that regulates the transcriptional activity of a proto-oncogene, c-Myc (Fujioka et al., 2001 ).
Among the DEGs in the PFC that were up-regulated in the 'hypercholesterolemia plus hypertension' group vs. 'sham operated controls' on a normal diet, CIDEC had the highest fold change, followed by FSHR, and FGFBP2. CIDEC and FSHR have been mentioned above. FGFBP2 (fibroblast growth factor binding protein 2) is also known as killer-specific secretory protein of 37 kDa (KSP37) and is expressed in cytotoxic T lymphocytes and natural killer cells (Ogawa et al., 2001) . It has been suggested as a prognostic marker for ovarian carcinoma (Elgaaen et al., 2010) . Among the DEGs that were down-regulated in the 'hypercholesterolemia plus hypertension' group vs. 'sham operated controls' on a normal diet were GAPDHS, Italics denotes DEG that is in common between the PFC and MCA with more than 4-fold change in the MCA. FAM184B, and TTR. FAM184B has been mentioned above. GAPDHS (glyceraldehyde-3-phosphate dehydrogenase, spermatogenic), a paralog of glyceraldehyde-3-phosphate dehydrogenase (GAPD), is expressed in the testis and lymphoid cell lines, while the brain has a much lower expression (Li et al., 2004) . This paralog is associated with age of onset of AD before 75 (Li et al., 2004) , and has been suggested as a susceptibility gene for AD (Bertram et al., 2007) . TTR (transthyretin) is a conserved serum and cerebrospinal fluid protein that transports thyroid hormone and holo retinol binding protein (Buxbaum and Reixach, 2009 ). TTR has been proposed to prevent senile plaque formation by binding to Ab (Schwarzman et al., 1994) to prevent its aggregation (Liu and Murphy, 2006) and formation of oligomers (Buxbaum and Reixach, 2009 ). Cerebrospinal fluid and plasma TTR levels have been suggested as markers for AD, since lower TTR levels have been found in patients with AD (Perrin et al., 2011; Velayudhan et al., 2012) . DEGs in the PFC were further analyzed by IPA software to elucidate possible functional interactions between genes. The network with the largest number of up-regulated genes after hypercholesterolemia included many genes related to the 'node molecule' ERK1/2. The network with the largest number of downregulated genes after hypercholesterolemia showed many genes related to Akt, Cyclin A, Cyclin E, E2f, Hdac, Histone h4, and the 20S proteasome. The network with the largest number of up-regulated genes after hypercholesterolemia plus hypertension included many genes related to GPCR. The network with largest number of downregulated genes after hypercholesterolemia plus hypertension showed many genes related to Beta tubulin, Cyclin E, ERK1/2, growth hormone, Insulin, LDL, MAP2K1/2, Mek, STAT5a/b and Tgf b.
In this study, we also compared the differentially expressed genes in the PFC and the middle cerebral artery (MCA) in rabbits with hypercholesterolemia. Results showed many DEGs in common, between the PFC and those in our previous study on the middle cerebral artery (MCA) (Ong et al., 2013) . These are highlighted in Tables 1e6. Moreover, the DEGs from the PFC and MCA tended to fall into the same gene networks, with many common 'node molecules'. These included: proteasome, insulin, Akt, ERK1/2, histone, IL12, interferon alpha and NFkB. Of these, PSMB4, PSMD4, PSMG1 were chosen as representatives of genes related to proteasome for further analysis, together with INS and APP, by quantitative RT-PCR. Results showed that PSMB4, PSMD4, and PSMG1 were significantly downregulated as a result of hypercholesterolemia, whereas no significant change was observed in the mRNA expression of INS and downregulation was found in the mRNA for APP. (1) Reduced proteolytic activity of 26S proteasome, a large multiprotein complex with a 20S core structure and a 19S regulator that is involved in the cellular protein degradation system, has been detected in the cerebral cortex of post-mortem human AD brains (Lopez Salon et al., 2000) ; and aberrant proteasome activity has been suggested as one of the factors contributing to Ab toxicity (Hegde and Upadhya, 2011; Shim et al., 2011) . PSMB4 is the gene that encodes the b7 subunit of the 20S core complex. A previous study has reported that the CRBN gene, which is related to mental retardation, suppresses proteasome activity through binding to PSMB4 (Lee et al., 2012) . PSMD4 encodes S5a, a non-ATPase subunit of the 19S regulator responsible for proteasome-substrate recognition. S5a is regulated at the transcriptional level by anti-apoptotic signals (Gus et al., 2007) . PSMG1, also known as Down syndrome critical region 2 (DSCR2), is linked to Down syndrome (Song et al., 2008) and Crohn's disease (Wagner et al., 2010 (Wagner et al., , 2013 . PSMG1 protein is a chaperone protein which promotes assembly of the 20S proteasome as part of a heterodimer with PSMG2. It also inhibits the transcriptional activity of a nuclear receptor, the peroxisome proliferator-activated receptor beta (Song et al., 2008) . (2) Although the mRNA expression of insulin (INS) was unchanged in hypercholesterolemic rabbits, other studies have highlighted a role of insulin-degrading enzyme (IDE), a Zn 2þ metalloproteinase that degrades both insulin and Ab, in AD. Competition between insulin and Ab for IDE could affect Ab degradation and facilitate the formation of senile plaques (Sebastiao et al., 2014) . Other studies have demonstrated a relation between cholesterol and sphingolipid-rich rafts and IDE-mediated Ab degradation (Bulloj et al., 2008) . For the 'node molecules' that have yet to be analyzed by RT-PCR (3) the Akt Pathway, or PI3K-Akt Pathway is a signal transduction pathway that promotes survival and growth in response to extracellular signals. Akt phospshorylation via a7 nicotinic or NMDA receptor activation occurs after acute exposure to Ab (Abbott et al., 2008) . (4) The MAPK/ERK pathway transmits signals from cell surface receptors to the nucleus by adding a phosphate group to a neighboring protein to act as an "on" or "off" switch. Increased ERK1/2 activity has been found in AD brain (Russo et al., 2002) where it could affect the processing of APP and phosphorylation of Tau (Guise et al., 2001 ). (5) Changes in histones have been associated with cognitive deficits including those in AD (Graff et al., 2012; Peleg et al., 2010) . Histone h3 is particularly important for learning and memory (Chwang et al., 2006; Day and Sweatt, 2011; Levenson et al., 2004) and hyperacetylation of histone h3 by histone acetyltransferase p300 has been reported in the promoter of AD-related genes such as presenilin-1and beta-site amyloid precursor protein cleaving enzyme 1 (BACE1). This suggests a role of p300 in increasing the expression of these genes (Lu et al., 2014) . (6) Interleukin 12 (IL-12) is an interleukin that is produced by dendritic cells, macrophages, neutrophils in response to antigenic stimulation and enhances the cytotoxic activity of these cells. Suppression of IL12 expression results in decreased Ab plaque burden and modulates cognitive impairment in a mouse model of AD (Vom Berg et al., 2012) . (7) Interferons activate immune cells such as natural killer cells and macrophages and increase host defenses by up-regulating antigen presentation. Increased interferon alpha has been found in the brains of AD patients and mouse models of AD, whilst ablation of interferon alpha receptor 1 expression prevents Ab toxicity (Taylor et al., 2014) . (8) The NFkB (nuclear factor kB) family includes transcription factors that play important roles in inflammation, immunity, cell proliferation, differentiation and survival (Oeckinghaus and Ghosh, 2009) . NFkB regulates the expression of BACE1 which generates Ab from APP (Rossner et al., 2006) . Possible links between some of the node molecules and Ab are summarized in Fig. 10B .
In this study we also confirmed an earlier report that intracellular Ab is present in the cerebral cortex of rabbits with hypercholesterolemia (Sparks et al., 1994) , and extended this observation to rabbits with hypertension. Ab immunohistochemistry was carried out using a widely-used monoclonal antibody, 4G8 Dasari et al., 2011; Ly et al., 2011; Ramakrishnan et al., 2009 ). This antibody has been used to detect Ab in rabbits Dasari et al., 2011) . Immunohistochemical analysis showed greater number of labelled cells in the PFC of rabbits after hypercholesterolemia and/or hypertension, compared to controls. Ab is generated from APP via the amyloidogenic pathway (Hardy and Selkoe, 2002) , and is a key component of senile plaques in AD (Blennow et al., 2006) . Results suggest that hypercholesterolemia and/or hypertension favors the amyloidogenic pathway, leading to increased intracellular Ab. The increase in Ab was despite a small downregulation of APP mRNA in the cortex as detected by quantitative RT-PCR. In view of our present finding that proteasome components are downregulated and previous reports that Ab is degraded by the 26S proteasome (Lopez Salon et al., 2000) , we postulate that the intracellular deposits of Ab may partly be due to decreased proteasome activity. Nonetheless, it is noted that the extent of down-regulation of mRNAs for PSMB4, PSMD4, and PSMG1 were at most 20%, hence, the increase in Ab is likely not only due to reduced proteasomal degradation, but also increased activity of b-and g-secretases. This notion is consistent with previous studies which showed that cholesterol affects the activity of b-and g-secretases. Inhibition of cholesterol biosynthesis reduces g-secretase activity and amyloid-b generation (Kim et al., 2016) . A biphasic relationship between membrane cholesterol and betasecretase activity in SH-SY5Y cells and in human platelets has also been described, with higher cholesterol levels inducing increased b-secretase activity (Liu et al., 2009 ). Moreover, Niemann-Pick type C cells that have increased cellular cholesterol content show cholesterol-dependent decrease in APP expression at the cell surface, but increased APP processing through the b-secretase pathway (Malnar et al., 2010) .
The possible mechanisms through which high serum cholesterol could affect gene expression in the brain remain to be clarified. Although the blood brain barrier (BBB) is an effective barrier against entry of serum cholesterol into the brain under normal conditions, disruption of the BBB has been reported in cholesterolfed rabbits (Chen et al., 2008; Sparks et al., 2000) , and increased brain cholesterol has been found in transgenic mice with hypercholesterolemia (Howland et al., 1998; Refolo et al., 2000) . Cholesterol can also be oxidized to cholesterol oxidation products or oxysterols either directly or through the action of enzymes, and some of the oxysterols e.g. 27-hydroxycholesterol, are able to cross Fig. 13 . Number of Ab-immunostained cells in layer III (A) and layer V (B) of the PFC of the 'sham operated control' rabbits (control); 'hypercholesterolemia plus sham' rabbits (HC); 'hypercholesterolemia plus hypertension' rabbits (HCHT); and 'hypertension only' rabbits (HT). Possible significant differences were analyzed by one-way ANOVA with Bonferroni's multiple comparison post-hoc test. Each bar in the diagram indicates mean þ standard error (n ¼ 4 in each group). * indicated significant difference compared with control. **P < 0.01 and ***P < 0.001. # indicated significant difference compared with HT. # P < 0.05 and ## P < 0.01.
the BBB to enter the brain (Heverin et al., 2005) . High levels of 27-hydroxycholesterol are present in the brains of AD patients (Shafaati et al., 2011) which could be a link between serum cholesterol and AD pathology (Ghribi, 2008) . Oxysterols decrease gene expression by blocking the sterol regulatory element binding protein (SREBP) pathway, but increase gene expression by binding to liver X receptor (LXR) nuclear receptors (Brown and Jessup, 2009) . SREBP is a transcription factor for genes involved in biosynthesis of fatty acids and cholesterol (Goldstein et al., 2006) . Oxysterols cause the retention of SREBP in the endoplasmic reticulum (Radhakrishnan et al., 2007) , thus preventing its translocation to the nucleus and transcription of these genes. On the other hand, oxysterols are able to activate LXR, to increase the expression of other genes involved in cholesterol export, such as ABCA1, ABCG1 and APOE (Bj€ orkhem and Meaney, 2004; Brown and Jessup, 2009) . It is possible that increases or decreases in gene expression in the PFC after hypercholesterolemia may be due to effects of oxysterols on SREBP or LXR pathways.
In conclusion, the present study has elucidated genes and functional networks that are altered in the PFC after hypercholesterolemia and/or hypertension, and verified decreases in proteasome related genes by quantitative RT-PCR. Further work is necessary to relate these gene expression changes to the behavior of the rabbits. Knowledge of altered gene networks during hypercholesterolemia and/or hypertension could inform our understanding of the link between these conditions and cognitive deficits in vascular dementia and AD.
